Yang Lu
Vermogen: 204 M $ op 31-05-2026
Vermogen: 204 M $ op 31-05-2026
Yang Lu is the founder of Adlai Nortye Ltd., where he currently serves as the Chairman & Chief Executive Officer.
He founded the company in 2018.
Mr. Lu previously worked as the Managing Director at Sinopep-Allsino Bio Pharmaceutical Co., Ltd. from 2004 to 2006.
Mr. Lu holds an MBA from China Europe International Business School, which he obtained in 2012.
He also completed his undergraduate studies at Xiamen University in 2002.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2026 | 16.990.000 ( 100% ) | 203 M $ | 31-05-2026 | |
ADLAI NORTYE LTD. 0,32% | 13-05-2026 | 299.970 ( 0,32% ) | 1 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ADLAI NORTYE LTD. | Algemeen Directeur | 09-05-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
| JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD. | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xiamen University
Xiamen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinopep-Allsino Bio Pharmaceutical Co., Ltd.
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development, production and sale of peptide and small molecule chemical drugs | Health Technology |
Adlai Nortye Ltd.
Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau